Literature DB >> 15870572

New and classic insights into presumed ocular histoplasmosis syndrome and its treatment.

Alejandro Oliver1, Thomas A Ciulla, Grant M Comer.   

Abstract

PURPOSE OF REVIEW: Presumed ocular histoplasmosis syndrome classically presents with atrophic choroidal scars, which are thought to progress into choroidal neovascularization in a small proportion of patients. The pathophysiology of the disease, including its underlying etiology, continues to be controversial and subject to ongoing research. Even more important is the controversy that surrounds the optimal treatment for choroidal neovascularization in patients with presumed ocular histoplasmosis, in particular that of subfoveal localization. RECENT DEVELOPMENTS: Intense efforts oriented toward defining the most beneficial therapeutic modality have resulted in some well-designed, large studies that evaluated submacular surgery, photodynamic therapies, and anti-angiogenic therapies, as well as small pilot studies exploring new therapeutic approaches for choroidal neovascularization.
SUMMARY: Important results obtained by these studies were recently made public, and the conclusions that may be drawn from them, as well as an update on findings concerning presumed ocular histoplasmosis etiology, epidemiology, and pathophysiology are presented in this report.

Entities:  

Mesh:

Year:  2005        PMID: 15870572     DOI: 10.1097/01.icu.0000161228.21797.d9

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  3 in total

1.  The eyes: a window into the past.

Authors:  Nancy F Crum-Cianflone
Journal:  Cleve Clin J Med       Date:  2010-07       Impact factor: 2.321

2.  Acute systemic histoplasmosis associated with chorioretinitis in an immunocompetent adolescent.

Authors:  Brian Fowler; Christopher Shen; Joseph Mastellone; Edward Chaum
Journal:  Digit J Ophthalmol       Date:  2011-08-15

Review 3.  Infectious optic neuropathies: a clinical update.

Authors:  Rim Kahloun; Nesrine Abroug; Imen Ksiaa; Anis Mahmoud; Hatem Zeghidi; Sonia Zaouali; Moncef Khairallah
Journal:  Eye Brain       Date:  2015-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.